152 related articles for article (PubMed ID: 36041227)
1. A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.
Scordo M; Shah GL; Adintori PA; Knezevic A; Devlin SM; Buchan ML; Preston EV; Lin AP; Rodriguez NT; Carino CA; Nguyen LK; Sitner NC; Barasch A; Klang MG; Maloy MA; Mastrogiacomo B; Carlow DC; Schofield RC; Slingerland AE; Slingerland JB; Stein-Thoeringer CK; Lahoud OB; Landau HJ; Chung DJ; van den Brink MRM; Peled JU; Giralt SA
Cancer; 2022 Nov; 128(21):3850-3859. PubMed ID: 36041227
[TBL] [Abstract][Full Text] [Related]
2. Myeloma, melphalan, and the taste of transplantation.
Banerjee R
Cancer; 2022 Nov; 128(21):3784-3786. PubMed ID: 36041229
[No Abstract] [Full Text] [Related]
3. Association of oral toxicity and taste changes during hematopoietic stem cell transplantation: a preliminary study.
Ferreira MH; Mello Bezinelli L; de Paula Eduardo F; Lopes RM; Pereira AZ; Hamerschlack N; Corrêa L
Support Care Cancer; 2020 Mar; 28(3):1277-1287. PubMed ID: 31236700
[TBL] [Abstract][Full Text] [Related]
4. Pilot Trial of Homebound Hematopoietic Cell Transplantation.
Landau HJ; Orlando E; Rodriguez ES; Applebaum A; Mitchell HR; Peled JU; Khan N; Funnell T; Chung D; Scordo M; Shah GL; LeStrange NJ; Hambright KA; McElrath CM; Cazeau N; Devlin SM; Perales MA; Giralt SA
Transplant Cell Ther; 2022 Dec; 28(12):832.e1-832.e7. PubMed ID: 36182105
[TBL] [Abstract][Full Text] [Related]
5. Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myeloma.
Nampoothiri RV; Kasudhan KS; Patil AN; Malhotra P; Khadwal A; Prakash G; Jain A; Malhotra S; Verma Attri S; Varma N; Varma S; Lad DP
Bone Marrow Transplant; 2019 Dec; 54(12):2088-2095. PubMed ID: 31406224
[TBL] [Abstract][Full Text] [Related]
6. Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial.
Bashir Q; Thall PF; Milton DR; Fox PS; Kawedia JD; Kebriaei P; Shah N; Patel K; Andersson BS; Nieto YL; Valdez BC; Parmar S; Rondon G; Delgado R; Hosing C; Popat UR; Oran B; Ciurea SO; Lin P; Weber DM; Thomas SK; Lee HC; Manasanch EE; Orlowski RZ; Williams LA; Champlin RE; Qazilbash MH
Lancet Haematol; 2019 May; 6(5):e266-e275. PubMed ID: 30910541
[TBL] [Abstract][Full Text] [Related]
7. Unlocking the Complex Flavors of Dysgeusia after Hematopoietic Cell Transplantation.
Scordo M; Shah GL; Peled JU; Preston EV; Buchan ML; Epstein JB; Barasch A; Giralt SA
Biol Blood Marrow Transplant; 2018 Mar; 24(3):425-432. PubMed ID: 29051023
[TBL] [Abstract][Full Text] [Related]
8. Fractionated stem cell infusions for patients with plasma cell myeloma undergoing autologous hematopoietic cell transplantation.
Landau H; Wood K; Chung DJ; Koehne G; Lendvai N; Hassoun H; Lesokhin A; Hoover E; Zheng J; Devlin SM; Giralt S
Leuk Lymphoma; 2016 Aug; 57(8):1781-5. PubMed ID: 26758672
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of High-Dose Propylene Glycol-Free Melphalan in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Dhakal B; D'Souza A; Lakshman A; Hamadani M; Chhabra S; Thompson R; Shah N; Pasquini M; Hari P
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1610-1614. PubMed ID: 29751116
[TBL] [Abstract][Full Text] [Related]
10. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
11. Symptom experience of multiple myeloma (syMMex) patients treated with autologous stem cell transplantation following high-dose melphalan: a descriptive longitudinal study.
Naegele M; Kirsch M; Ihorst G; Fierz K; Engelhardt M; De Geest S
Support Care Cancer; 2018 Mar; 26(3):833-841. PubMed ID: 28918604
[TBL] [Abstract][Full Text] [Related]
12. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial.
Deng G; Giralt S; Chung DJ; Landau H; Siman J; Search B; Coleton M; Vertosick E; Shapiro N; Chien C; Wang XS; Cassileth B; Mao JJ
Support Care Cancer; 2018 Feb; 26(2):657-665. PubMed ID: 28920142
[TBL] [Abstract][Full Text] [Related]
13. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
[TBL] [Abstract][Full Text] [Related]
14. Symptom burden after autologous stem cell transplantation for multiple myeloma.
Campagnaro E; Saliba R; Giralt S; Roden L; Mendoza F; Aleman A; Cleeland C; Weber D; Brown J; Anderson KO
Cancer; 2008 Apr; 112(7):1617-24. PubMed ID: 18260091
[TBL] [Abstract][Full Text] [Related]
15. Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant.
Sweiss K; Vemu B; Hofmeister CC; Wenzler E; Calip GS; Galvin JP; Mahmud N; Rondelli D; Johnson JJ; Patel P
Br J Clin Pharmacol; 2020 Nov; 86(11):2165-2173. PubMed ID: 32285957
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention.
Okada N; Hanafusa T; Abe S; Sato C; Nakamura T; Teraoka K; Abe M; Kawazoe K; Ishizawa K
Support Care Cancer; 2016 Sep; 24(9):3979-85. PubMed ID: 27129837
[TBL] [Abstract][Full Text] [Related]
17. The experience of dysgeusia in allogeneic haematopoietic cell transplantation survivors: a qualitative study.
Bomben D; Bin A; Venturini M; Bulfone T; Ghirotto L; Bressan V
Support Care Cancer; 2019 Dec; 27(12):4607-4613. PubMed ID: 30937598
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.
Saad A; Mahindra A; Zhang MJ; Zhong X; Costa LJ; Dispenzieri A; Drobyski WR; Freytes CO; Gale RP; Gasparetto CJ; Holmberg LA; Kamble RT; Krishnan AY; Kyle RA; Marks D; Nishihori T; Pasquini MC; Ramanathan M; Lonial S; Savani BN; Saber W; Sharma M; Sorror ML; Wirk BM; Hari PN
Biol Blood Marrow Transplant; 2014 Mar; 20(3):402-408.e1. PubMed ID: 24342394
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma.
Barta SK; Jain R; Mazumder A; Carter J; Almanzar L; Browne R; Shahnaz S; Elkind R; Kaminetzky D; Battini R; Derman O; Kornblum N; Verma A; Braunschweig I
Clin Lymphoma Myeloma Leuk; 2017 Oct; 17(10):650-657. PubMed ID: 28684379
[TBL] [Abstract][Full Text] [Related]
20. Taste disorders following cancer treatment: report of a case series.
Epstein JB; de Andrade E Silva SM; Epstein GL; Leal JHS; Barasch A; Smutzer G
Support Care Cancer; 2019 Dec; 27(12):4587-4595. PubMed ID: 30927113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
